VAERS reports by lot

GSK Hepatitis A lot 299X2: VAERS reports

34 VAERS reports list lot 299X2 as a GSK Hepatitis A vaccine, received between 2019-05-16 and 2022-04-06. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
34
Reports
6%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological2333%
Gastrointestinal1521%
Cardiac / Cardiovascular1014%
Injection-site / Local reaction710%
General / Systemic (non-local)69%
Dermatological (non-injection-site)34%
Allergic / Anaphylactic23%
Psychiatric / Neuropsychiatric23%
Thrombotic / Hematological11%
Musculoskeletal11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida9
North Carolina6
Michigan3
Texas2
Missouri2
Georgia2
Tennessee2
Indiana1
Iowa1
Kentucky1
Virginia1
Alabama1

Reports by month received

2019-051
2019-064
2019-075
2019-088
2019-093
2019-102
2019-111
2020-012
2020-021
2021-051
2021-062
2021-072
2022-031
2022-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.